glutathione peroxidase reduced Peroxidase-1 in Health and Disease: From Molecular Mechanisms to Therapeutic Opportunities Measurement of superoxide dismutase, catalase

Future perspectives The treatment landscape for patients with diabetes and CKD is rapidly evolving with SGLT2 inhibitors and GLP1 agonists

Idiopathic Parkinsons disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients

Redox remodeling as an immunoregulatory strategy

*Correspondence: Pedro Grandes, [email protected] These authors have contributed equally to this work and share last authorship This article was submitted to Nutrition, Psychology and Brain Health, a section of the journal Frontiers in Nutrition Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

This directly and significantly lowers the production of pro-inflammatory cytokines like Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-), effectively cooling the systemic inflammatory fire that drives chronic illness symptoms